Trial for Children With Eosinophilic Esophagitis (EoE)


Clinical Trial

Offered by: Nemours
Location: Orlando, Fla.

Trial Name

Oral Budesonide Suspension (OBS) In Adolescent Subjects (12-17 Years of Age) With Eosinophilic Esophagitis: A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Extension

What is the trial about?

To test a drug called MB-9, an investigational (experimental) drug being developed by Meritage Pharma, Inc. for the treatment Eosinophilic esophagitis (EoE).

Who can participate?

Children with Eosinophilic esophagitis (EoE).

What is involved?

Length of study is 22-24 weeks. Procedures and tests to be done include physical exam, endoscopy, blood and urine samples.

Contact Nemours Clinical Trials

Trial Name: Oral Budesonide Suspension (OBS) In Adolescent Subjects (12-17 Years of Age) With Eosinophilic Esophagitis: A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Extension

Contact Information

(800) 354-5690
ClinicalTrials@nemours.org